However, GLUT4 overexpression can alter insulin sensitivity and kinase activities in an insulin resistance context, which limits its use in studies involving genetic or pharmacological manipulation with endogenous GLUT4. The gene discussed is SLC2A4; the disease is Insulin resistance.